Tanta University
Tanta, El-Gharbia, 31527, Egypt
Location status: Recruiting
NCT Number: NCT06507410
The objective of this study was to compare safety, satisfaction, and efficiency outcomes of propofol versus propofol with clonidine in patients undergoing colonoscopy.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
Tanta, El-Gharbia, 31527, Egypt
Location status: Recruiting
Colonoscopy is one of the most common procedures in the world, Colonoscopy is a procedure often performed for prevention, diagnosis, and treatment of a variety of symptoms and diseases of the lower digestive tract, and sedation or anesthesia should be considered as an important tool to increase its effectiveness.
Sedation and analgesia are considered key components, as they reduce anxiety and discomfort and therefore improve the procedure tolerability and patient satisfaction, minimize risk of complications and provide better conditions for the examination.
Propofol may be used alone or in combination with opioids and/or benzodiazepines.
The use of propofol alone requires higher doses, which may lead to increased incidence of side effects. However, the risks and benefits of adding analgesic and sedative to propofol are controversial, and the selection of drugs is a crucial factor in determining the outcomes.
Clonidine apparently produces its sedative and anaesthetic-sparing effects by stimulation of centrally located alpha2 adrenoceptors. Analgesia seems to be mediated mainly by activation of alpha2 adrenoceptors in the dorsal horn of the spinal cord.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Continuous propofol infusion will be given with syringe pump for maintenance, with the initial rate set at 25-75 mic/kg/min IV during the first 10-15 min. To avoid administering sedatives at rates greater than clinically necessary, infusion rates will be gradually titrated to 25-50 mic/kg/min and regulated with the clinical response, with an onset of peak drug action expected to occur within 2 min.
Patients will receive 2 μg/kg of clonidine for injection intravenously 30 min before induction of sedation, administered over 10 min.
Time frame: 24 hours postoperatively
Patient's satisfaction level will be assessed with a Likert five-item scoring system (1 = Not at all satisfied, 2 = slightly satisfied, 3 = somewhat satisfied, 4 = very satisfied, and 5 = extremely satisfied).
Time frame: Till the end of surgery
Heart rate will be recorded at 30 minutes before induction, at induction, and at the end of surgery.
Time frame: Till the end of surgery
Mean arterial blood pressure will be recorded at 30 minutes before induction, at induction, and at the end of surgery.
Time frame: 24 hours postoperatively
Side effects such as nausea and vomiting, psychological reactions will be noted.
Contact information is provided by the study sponsor or research team.
Tanta University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07062497
Ambulatory Surgical Procedures, Clonidine
Rio de Janeiro, Brazil
View Trial DetailsNCT07567495
Cesarean Delivery, Cesarean Delivery; Neuraxial Opioids
New York, United States
View Trial DetailsNCT06716840
Cardiac Surgery, Intensive Care
Hangzhou, Zhejiang, China
View Trial DetailsNCT07649746
Colonoscopy, Endoscopic Retrograde Cholangiopancreatography (ERCP)
View Trial Details